Zhejiang Ausun Pharmaceutical
China 3 duplicate records merged Updated 9 July 2026
Zhejiang Ausun Pharmaceutical is an API manufacturer based in China. It holds 8 valid CEPs across a filed portfolio of 11 molecules. Its GMP standing is certified by EMA.
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Taizhou, China | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Ticagrelor | EDQM, SFDA (Saudi Arabia) | 3 |
| Entecavir | EDQM, SFDA (Saudi Arabia) | 2 |
| Sugammadex | SFDA (Saudi Arabia) | 2 |
| Apixaban | SFDA (Saudi Arabia) | 1 |
| Entecavir Monohydrate | EDQM | 1 |
| Febuxostat | SFDA (Saudi Arabia) | 1 |
| Imatinib Mesilate | EDQM | 1 |
| Latanoprost | EDQM | 1 |
| Nebivolol | EDQM | 1 |
| Pilocarpine | EDQM | 1 |
Show all 11 molecules on file
| Posaconazole | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| EMA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Zhejiang Ausun Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates